Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor and G-CSF for peripheral blood stem cell mobilization before autologous stem cell transplantation
2008-000689-21Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of plerixafor in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL) and multiple myeloma (MM), sponsored by Sanofi. Primary endpoints: Quantity of CD34+ cells harvested, Engraftment and 2 more. Started Jun 2008; status: completed.
02
Drugs
plerixafor
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)multiple myeloma (MM)
Beyond the preview
Go deeper on 2008-000689-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000689-21.